Sorcero
Washington, US · Founded 2017 · Delaware corporation · 7 known investors
Sorcero develops AI-powered intelligence solutions for the life sciences industry, helping companies accelerate patient access to therapies and improve medical research and communications. The platform uses medically-tuned large language models to support pharmaceutical, biotech, and healthcare organizations.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical Devicesin /sorceroai@SorceroCo
Founders & leadership
DD

Dipanwita DasCEO and Co-founder
OL
Oliver LibbyDirector
PH
Peter Hart CallahanDirector
DG
Daniel GoldsmithDirector
JP
Jonathan PhilipsDirector
RG

Richard GravesExecutive Officer, Director
CP
Claiborne P. DemingDirector
WB
Walter BenderCTO
KG
Karl GemperliDirector
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$18.7MraisedOct 2025 · 8 investors · Other TechnologyRule 506(b)
▶$18.7MraisedOct 2025 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Oliver LibbyDirector
- Peter Hart CallahanDirector
- Dipanwita DasExecutive Officer, Director
- Daniel GoldsmithDirector
- Jonathan PhilipsDirector
- Richard GravesExecutive Officer, Director
- Karl GemperliDirector
- Offering amount
- $21M
- Amount sold
- $18.7M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedSep 2021 · 53 investors · Other TechnologyRule 506(b)
▶$14.5MraisedSep 2021 · 53 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Claiborne P. DemingDirector
- Oliver LibbyDirector
- Dipanwita DasExecutive Officer, Director
- Walter BenderExecutive Officer
- Richard GravesExecutive Officer, Director
- Offering amount
- $15.7M
- Amount sold
- $14.5M
- Minimum investment
- $1
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Sorcero raises $42.5 million for AI adoption in life sciencesdruganddeviceworld.com · 2025
- Sorcero raises $42.5m to support global expansionmedicaldevice-network.com · 2025
- Sorcero Raises $42.5M in Series B Fundingfinsmes.com · 2025
- Sorcero: $42.5 Million Series B Raised To Advance Expansion Of Its Life Sciences AI Platformpulse2.com · 2025
- Exclusive: Sorcero raises $42.5M for agentic AI pharma marketing and safetyaxios.com · 2025
- Sorcero Secures $42.5M Series B Financing Led by NewSpring Capital to Scale Its AI Platform, Accelerate Expansion Across Life Sciencesfinance.yahoo.com · 2025